Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Tianyi Pharmaceutical Technology is a specialized pharmaceutical research and development enterprise based in Shenzhen, China. Established in 2010, the company focuses on the discovery and development of small molecule chemical drugs, targeting significant unmet needs in oncology, cardiovascular, and infectious diseases. Tianyi operates a dual business model, advancing its own internal pipeline of innovative chemical entities while providing high-quality contract research organization (CRO) services to domestic and international partners. Their technical expertise encompasses medicinal chemistry, pharmaceutical analysis, and the rigorous consistency evaluation required for generic drug approval in the Chinese market. Recognized as a National High-tech Enterprise, the firm is committed to bridging the gap between laboratory innovation and commercial pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Tianyi Pharmaceutical Technology.